CN114601800A — 一种甲磷丙泊酚钠无菌粉针剂及其制备方法
Assigned to Hubei Longxiang Pharmaceutical Tech Co ltd · Expires 2022-06-10 · 4y expired
What this patent protects
本发明属于化学药物制剂领域,具体涉及一种甲磷丙泊酚钠无菌制剂及其制备方法。所述无菌制剂具体为一种无菌注射用粉针剂,其各组分及其用量份数为:甲磷丙泊酚钠100~200份、稀释剂45~100份、稳定剂0.5~2份。本发明无菌注射用粉针剂,采用无菌喷雾干燥工艺制备无菌粉末,并对喷雾干燥工艺进行了深入的研究,最终可以获得粒径可控的无菌粉末,易于灌装。该工艺制备的样品,稳定性好,易于储存和运输,注射剂易于复溶。
USPTO Abstract
本发明属于化学药物制剂领域,具体涉及一种甲磷丙泊酚钠无菌制剂及其制备方法。所述无菌制剂具体为一种无菌注射用粉针剂,其各组分及其用量份数为:甲磷丙泊酚钠100~200份、稀释剂45~100份、稳定剂0.5~2份。本发明无菌注射用粉针剂,采用无菌喷雾干燥工艺制备无菌粉末,并对喷雾干燥工艺进行了深入的研究,最终可以获得粒径可控的无菌粉末,易于灌装。该工艺制备的样品,稳定性好,易于储存和运输,注射剂易于复溶。
Drugs covered by this patent
- Veklury (remdesivir) · Gilead Sciences
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.